Table 6.
Analysis of change from baseline to study end baseline Patient Activation Measure level (continued).
| Outcome | Baseline PAMa level 3 | Baseline PAM level 4 | ||||
|
|
Control, ORb (95% CI) | Intervention, OR (95% CI) | P value | Control, OR (95% CI) | Intervention, OR (95% CI) | P value |
| PAM score | 6.29 (2.24 to 10.35) | 4.26 (0.88 to 7.64) | .45 | −1.44 (−7.39 to 4.50) | −10.49 (−16.54 to −4.44) | .04 |
| Summary of Diabetes Self-Care Activities score | 6.49 (2.75 to 10.23) | 7.58 (4.44 to 10.73) | .66 | 7.02 (3.15 to 10.89) | 3.95 (−1.76 to 9.66) | .38 |
| Glycated hemoglobin | −0.49 (−0.83 to −0.16) | −0.04 (−0.25 to 0.16) | .02 | −0.57 (−1.11 to −0.03) | −0.09 (−0.55 to 0.36) | .18 |
| BMI (kg/m2) | −0.43 (−0.86 to 0.01) | −0.42 (−0.76 to −0.07) | .97 | −1.25 (−2.47 to −0.04) | −0.09 (−0.53 to 0.35) | .08 |
| Waist (inches) | −1.51 (−2.18 to −0.83) | −1.56 (−2.08 to −1.03) | .91 | −1.37 (−2.63 to −0.10) | −0.90 (−1.71 to −0.08) | .54 |
| Diastolic blood pressure (mm Hg) | −2.55 (−5.22 to 0.11) | −1.23 (−3.24 to 0.79) | .44 | −0.19 (−4.24 to 3.86) | −2.22 (−5.41 to 0.96) | .44 |
| Systolic blood pressure (mm Hg) | −4.33 (−9.20 to 0.53) | −1.58 (−6.34 to 3.19) | .43 | −2.78 (−12.44 to 6.89) | 1.69 (−5.17 to 8.56) | .46 |
| High-density lipoprotein cholesterol (mg/dL) | −0.93 (−2.84 to 0.99) | 0.12 (−2.56 to 2.81) | .53 | −2.44 (−4.91 to 0.02) | −1.03 (−6.10 to 4.05) | .62 |
| Low-density lipoprotein cholesterol (mg/dL) | −3.99 (−12.36 to 4.37) | 3.32 (−3.62 to 10.26) | .19 | −13.38 (−27.02 to 0.25) | −0.19 (−17.09 to 16.70) | .23 |
aPAM: Patient Activation Measure.
bOR: odds ratio.